pertuzumab (Q1998021)

From Wikidata
Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
pharmaceutical drug
  • 2C4 Antibody
  • MOAB 2C4
  • Monoclonal Antibody 2C4
  • Omnitarg
  • rhuMAb-2C4
  • RG-1273
Language Label Description Also known as
English
pertuzumab
pharmaceutical drug
  • 2C4 Antibody
  • MOAB 2C4
  • Monoclonal Antibody 2C4
  • Omnitarg
  • rhuMAb-2C4
  • RG-1273

Statements

subclass of
protein
0 references
facet of
breast cancer
0 references
legal status (medicine)
boxed warning
1 reference
reference URL
https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802
title
FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)
Commons category
Pertuzumab
0 references

Identifiers

HSDB ID
8141
1 reference
stated in
Hazardous Substances Data Bank
HSDB ID
8141
publication date
28 October 2019
title
Pertuzumab (English)
retrieved
10 May 2021
RxNorm ID
1298944
0 references
DrugBank ID
DB06366
0 references
UMLS CUI
C1328025
0 references
 
                Retrieved from "https://www.wikidata.org/w/index.php?title=Q1998021&oldid=2190020627"